Aim Immunotech Inc (AIM)
$0.45
0.02 (5.28%)
AIM Stock Quote Delayed 30 Minutes
Coronavirus Research Is the Key for AIM ImmunoTech Stock
One big breakthrough moment in coronavirus research could bring wealth to AIM ImmunoTech. It could also bring big gains to AIM stock.
11 Best Stocks to Buy for 2023
INSIDE: Investing legend Louis Navellier reveals his Top 11 Stocks for 2023 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
1.79M
PE Ratio
0.74
EPS
0.6
Volume (Avg. Vol.)
136,363
Day's Range
$0.44 - $0.47
52-Week Range
$0.29 - $1.38
Dividend & Yield
N/A (N/A)
AIM Stock Predictions, Articles, and Aim Immunotech Inc News
Read the Label Before Buying AIM Stock
One of the few sectors that have enjoyed upside is the pharmaceutical industry. In particular, AIM stock has jumped on a possible Covid-19 treatment. Nevertheless, you want to look carefully at the label before jumping aboard.
In the Coronavirus Vaccine Race, AIM Stock Isn’t a Likely Winner
AIM stock was a big winner on hopes it could join the response to the coronavirus. But its history suggests those hopes are too optimistic.
GT Biopharma News: GTBP Stock Spikes 26% on Coronavirus Treatment Hopes
GT Biopharma (GTBP) news for Tuesday about it working on a possible treatment for the coronavirus from China has GTBP stock heading higher.
AIM ImmunoTech News: AIM Stock Skyrockets 208% on Hopes for COVID-19 Treatment
AIM ImmunoTech (AIM) news for Monday concerning a possible treatment for the coronavirus from China has AIM stock rocketing higher.
